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1, Introduction 
Bacitracin A contains a thiazoline ring in the 
N-terminal portion of the molecule. The thiazoline 
ring has been thought o be synthesized by a cyclic 
condensation of isoleucylcysteine portion of the 
peptide [I 1. However, it has not been known when the 
thiazoline ring is formed in the process of bacitracin 
biosynthesis. 
The work described here shows that the enzyme- 
bound dipeptide, afirst intermediate peptide in 
peptide chain elongation in bacitracin biosynthesis 
121, contained athiazoline ring. This suggests hat the 
thiazoline ring is formed at the first step of peptide 
chain elongation in bacitracin biosynthesis. 
2. Materials 
Thiopropyl-Sepharose 6B was obtained from 
Pharmacia Fine Chemicals AB, Uppsala. The gel was a 
mercaptohydroxypropyl-2.pyridyl isulfide derivative 
of Sepharose 6B and it contained about 20 pm01 
2-pyridyl disulfide structure~ml swollen gel. Bacitracin 
(68.4 unitfmg) was obtained from Sigma Chemical 
Co., St Louis, MO. 
3, Me~ods 
3.1. Preparation of bacitracin synthetase 
Bacitracin synthetase was partially purified as in 
[3], and the Sephadex G-200 fraction was used 
throughout the work. 
ElsevierjNorth-Holland Biomedical Press 
The reaction mixture (1 .O ml) with L- [ 14C] phenyl- 
alanine was incubated for 3 h as in [3]. Carrier 
bacitracin (0.5 mg) was added and labeled bacitracin 
precipitated with saturated (NH&SO, was collected 
on a glass fiber filter as in [3]. The precipitate was 
dissolved in 4 ml methanol-water (I : 1). After centri- 
fugation for 10 mm at 1000 X g, the supernatant was 
evaporated to dryness. 
3.3. ~eparutio~ of the isol~cy~cy~tei~e dipeptide 
fraction 
The reaction mixture contained the following in 
0.8 ml final vol.: 40 pm01 potassium phosphate 
(pH 7.2), 8 pmol MgClz, 1.6 ymol ATP, 8 pmol 
dithiothreitol, 0.2 pmol L-isoleucine, 0.2 PCi L-[‘4C]- 
cystine (295 Cifmol) and 2 .l mg protein of the enzyme. 
After incubation for 40 min at 37*C, the protein 
containing enzyme-bound dipeptide was precipitated 
with 4 ml cold 5% trichloroacetic acid (TCA). The 
precipitate was collected onto a glass fiber filter and 
washed 5 times with 5 ml portions of coId 5% TCA. 
The fiter was dried in a stream of air at room 
temperature. The thin fti of the precipitate was 
stripped off from the filter and dissolved in 2 ml 
0.01 N KOH by stirring for 60 min at 2O’C. The solu- 
tion was incubated for 30 min at 50°C to liberate the 
covalently linked dipeptide. To the solution, 8 ml 
methanol was added and the mixture stored overnight 
at -10°C. The supernatant obtained by centrifugation 
was evaporated to dryness. The residue was dissolved 
in 0.2 ml water, then 3 ml methanol was added to the 
solution. After standing at 0°C for 30 mm, the mix- 
ture was centrifuged at 1500 X g for 10 min. The 
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supernatant was evaporated to dryness. 3.6. Assa_v of antibiotic activity 
In one experiment, 50 ~1 water was added to the 
residue, and the solution was applied to a silica gel 
thin-layer chromatogram which was developed in 
ethanol/28% NH40H/water (8: 1: 1). The dipeptide 
(RF 0.67) was located by a chromatogram scanner, 
eluted with the same solvent, and concentrated to 
dryness. 
3.4. Opening of the thiazoline ring by acid hydrolysis 
The labeled bacitracin and the dipeptide fraction 
were heated in 0.5 N HCl for 10 min at 100°C or for 
100 min at 60°C respectively, to open the thiazoline 
ring, [4]. When commercial bacitracin was used, 
75-80% of the thiazoline ring was hydrolyzed under 
these conditions. 
The antibacterial activity of bacitracin synthesized 
by the enzyme reaction was determined by an agar 
diffusion (paper-disc) method withMicrococcusflavus 
as test organism. The reaction mixture (2 ml) con- 
taining 2 mg protein of bacitracin synthetase, 2.5 mM 
each of the bacitracin-constituting amino acids and 
the other ingredients was incubated for 2.5 h as in [3]. 
After incubation, 8 ml methanol was added. The 
supernatant obtained by centrifugation was evaporated 
to dryness. The residue was extracted with methanol. 
The extract was evaporated to dryness and the residue 
was dissolved in 50 ~1 water. A paper disc was soaked 
in the solution and placed on an agar plate. 
4. Results 
3 5. Isolation of a thiol-containing peptide with thio- 
propyl-Sepharose 6B gel 4.1. Experiments with the labeled bacitracin 
The residue containing the labeled bacitracin or 
the labeled dipeptide was dissolved in 1 ml water and 
was divided into two equal portions. One portion of 
the solution was heated in 0.5 N HCl as mentioned 
above to open the thiazoline ring, then adjusted to 
pH 7 with 0.5 N KOH. The other portion was treated 
similarly except that heating was omitted. To the 
solution a sufficient amount of dithiothreitol was 
added to reduce the thiol-containing peptide, and left 
for 10 min at room temperature. Thiopropyl- 
Sepharose 6B gel (1 ml) suspended in 3 ml 0.05 M 
potassium phosphate buffer (pH 7.2) containing 5 M 
urea, 2 mM Tris-HCl buffer (pH 7.2) and 1 mM 
EDTA was bubbled with nitrogen to exclude air and 
added to the sample solution. The gel suspension was 
gently shaken in an atomosphere of Nz for 60 min at 
3O”C, then poured into a small column (4.5 X 100 mm). 
The eluate containing the non-attached peptide was 
collected. The column was washed with 25 ml 0.05 M 
phosphate buffer (pH 7.2) containing 1 mM EDTA, 
then with 15 ml 0.05 M phosphate buffer (pH 7.2) 
containing 1 M NaCl and 1 mM EDTA. The thiol-con- 
taining peptide was eluted with 20 mM 2-mercapto- 
ethanol containing 50 mM phosphate buffer (pH 7.8) 
and 1 mM EDTA (attached fraction). All the eluates 
were collected in 2.6 ml each and 1 mM portion of 
the eluate was counted in a liquid scintillation 
spectrometer. 
To know whether the bacitracin synthesized in the 
enzyme system contains a thiazoline ring in the 
molecule, [14C]phenylalanine-labeled bacitracin was 
treated with thiopropyl-Sepharose 6B gel. Table 1 
shows that 80% of the labeled bacitracin attached to 
the gel only after ring-opening treatment. This suggests 
that bacitracin synthesized by the in vitro system had 
a thiazoline ring. 
Since the thiazoline ring has been thought to be 
essential for antimicrobial activity of bacitracin, anti- 
microbial activity of the products formed by the 
enzyme system was examined. As shown in table 2, 
an amount of apparent antibacterial activity was 
produced in the complete system. This fact supports 
the result mentioned above. 
Table 1 
Binding profile of “‘C-labeled bacitracin to thiopropyl- 
Sepharose 6B gel 
Fraction Radioactivity (dpm) 
Non-treated Acid-treated 
Non-attached 53 080 7110 
Attached 820 38 140 
About 0.5 mg (SO 320 dpm) of bacitracin was used in each 
experiment 
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Table 2 
Formation of antimicrobial activity by the bacitracin 
synthetase 
Incubation system Bacitracin units 
Expt. 1 Expt. 2 
Complete (0 time) 
Complete (2.5 h) 
_ all amino acids 
- Asp and Asn 
0.25 0.48 
10 7.2 
0.25 _ 
_ 0.48 
4.2. Experiments with the labeled dipep tide 
Scan on the thin-layer chromatogram of the [14C] -
cysteine-labeled dipeptide fraction liberated from the 
enzyme protein by alkaline hydrolysis indicated that 
almost all the radioactivity was located in the position 
of the dipeptide, and that significant radioactivity was 
not detected in the positions of cystine and cysteine. 
Thus, the dipeptide fraction liberated by alkaline 
hydrolysis could be treated directly with thiopropyl- 
Sepharose gel without purification by thin-layer 
chromatography. Table 3 shows that the dipeptide has 
practically no free thiol groups, and the thiol group 
of the cysteine residue was liberated by the acid 
hydrolysis. These results suggest hat the dipeptide 
contains a thiazoline ring. 
To know whether the amino group of isoleucine 
residue of the dipeptide is free or blocked, [‘4C]iso- 
leucine-labeled dipeptide was oxidized by performic 
acid, and then analyzed by the dinitrofluorobenzene 
method [S] . About 70% of radioactivity was recovered 
as dinitrophenylisoleucine, indicating that the amino 
group of isoleucine residue was free. 
5. Discussion 
These results show that the thiazoline ring is 
formed at the first step of peptide chain elongation in 
bacitracin biosynthesis. This means that the other 
portion of the bacitracin molecule is not required for 
the thiazoline ring closure. 
It was reported in the attempt at organic synthesis 
of the thiazoline ring that the cysteine residue could 
be cyclized to a thiazoline ring under anhydrous 
conditions only when the a-amino group of the 
N-terminal amino acid residue adjacent to the cystelne 
residue had been protected by an acetyl [6] or a 
benzyloxycarbonyl group [7]. It was shown in the 
present experiments that o-amino group of the iso- 
leucine residue of the thiazoline ring-containing 
dipeptide was free. Thus, it is likely that the reac- 
tion of thiazoline ring formation in the present system 
is not spontaneous, but is catalyzed by an enzyme. 
The amount of the attached dipeptide fraction 
decreased by leaving it at room temperature for a long 
time, or by the performance of thin-layer chromatog- 
raphy, before opening the thiazoline ring. This may 
be attributed to the change by oxidation in the struc- 
ture of the thiazoline ring to a thiazole ring which is 
resistant to ring opening by heating in 0.5 N HCl [8]. 
Table 3 
Binding profile of the [ 14C] cysteine-labeled ipeptide to thiopropyl- 
Sepharose 6B gel 
Fraction Radioactivity (dpm) 
Expt. 1 Expt .2 Expt. 3 
_ + _ + + 
Non-attached 13 710 3390 13320 5270 10070 6060 
Attached 420 10 900 260 7980 360 3640 
In expts. 1 and 2, the dipeptide without purification by thin-layer chromatog- 
raphy (TLC) was used,and in expt. 3, it was purified by TLC. Radioactivities of the 
dipeptide used in each experiment in expts. 1,2 and 3 were 15 540 dpm, 15 320 dpm 
and 11 860 dpm, respectively. (-) not treated with 0.5 N HCl; (+) treated with 
0.5 N HCl 
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